🇺🇸 FDA
Patent

US 6323185

Anti-viral guanosine-rich oligonucleotides and method of treating HIV

expired A61KA61K31/70A61K31/711

Quick answer

US patent 6323185 (Anti-viral guanosine-rich oligonucleotides and method of treating HIV) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Nov 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Nov 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/70, A61K31/711, A61K31/7115, A61K31/7125